{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T21:48:16Z","timestamp":1794001696871,"version":"4.8.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T00:00:00Z","timestamp":1738540800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Medical Microbiology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.ijmm.2025.151649","type":"journal-article","created":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T16:34:18Z","timestamp":1738773258000},"page":"151649","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Pre-exposure to phage particles reduces their antibacterial therapeutic efficacy both in vitro and in vivo"],"prefix":"10.1016","volume":"318","author":[{"given":"Liwen","family":"Zhong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danjun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyi","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianhui","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangjian","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufeng","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2700-5800","authenticated-orcid":false,"given":"Zelin","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijmm.2025.151649_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.micres.2022.127155","article-title":"The resurgence of phage-based therapy in the era of increasing antibiotic resistance: From research progress to challenges and prospects","volume":"264","author":"Anyaegbunam","year":"2022","journal-title":"Microbiol. Res."},{"key":"10.1016\/j.ijmm.2025.151649_bib2","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1038\/s41467-024-47192-w","article-title":"Phage-specific immunity impairs efficacy of bacteriophage targeting Vancomycin Resistant Enterococcus in a murine model","volume":"15","author":"Berkson","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijmm.2025.151649_bib3","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.tim.2020.10.014","article-title":"The enemy of my enemy: new insights regarding Bacteriophage-Mammalian cell interactions","volume":"29","author":"Bodner","year":"2021","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.ijmm.2025.151649_bib4","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.chom.2019.01.020","article-title":"The innate sense of bacteriophages","volume":"25","author":"Bollyky","year":"2019","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ijmm.2025.151649_bib5","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/s41577-020-00410-0","article-title":"The role of IgG Fc receptors in antibody-dependent enhancement","volume":"20","author":"Bournazos","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ijmm.2025.151649_bib6","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12985-017-0701-0","article-title":"Characterization and complete genome of the virulent Myoviridae phage JD007 active against a variety of Staphylococcus aureus isolates from different hospitals in Shanghai, China","volume":"14","author":"Cui","year":"2017","journal-title":"Virol. J."},{"key":"10.1016\/j.ijmm.2025.151649_bib7","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1002\/med.21572","article-title":"Phage therapy: What factors shape phage pharmacokinetics and bioavailability? Systematic and critical review","volume":"39","author":"Dabrowska","year":"2019","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ijmm.2025.151649_bib8","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/s41591-021-01403-9","article-title":"Potent antibody-mediated neutralization limits bacteriophage treatment of a pulmonary Mycobacterium abscessus infection","volume":"27","author":"Dedrick","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.ijmm.2025.151649_bib9","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.3389\/fmicb.2018.01553","article-title":"Prevention of dermal abscess formation caused by Staphylococcus aureus using phage JD007 in nude mice","volume":"9","author":"Ding","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ijmm.2025.151649_bib10","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-25352-6","article-title":"Biological properties of Staphylococcus virus PhiSA012 for phage therapy","volume":"12","author":"Fujiki","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijmm.2025.151649_bib11","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3389\/fcimb.2018.00376","article-title":"Bacteriophage therapy: clinical trials and regulatory hurdles","volume":"8","author":"Furfaro","year":"2018","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.ijmm.2025.151649_bib12","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.copbio.2020.11.011","article-title":"Phage-specific antibodies","volume":"68","author":"Gembara","year":"2021","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.ijmm.2025.151649_bib13","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.chom.2019.01.008","article-title":"Expansion of bacteriophages is linked to aggravated intestinal inflammation and colitis","volume":"25","author":"Gogokhia","year":"2019","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ijmm.2025.151649_bib14","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nri1783","article-title":"Antiviral antibody responses: the two extremes of a wide spectrum","volume":"6","author":"Hangartner","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ijmm.2025.151649_bib15","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.idc.2020.10.003","article-title":"Staphylococcal skin and soft tissue infections","volume":"35","author":"Hatlen","year":"2021","journal-title":"Infect. Dis. Clin. North Am."},{"key":"10.1016\/j.ijmm.2025.151649_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.639570","article-title":"Immune response to therapeutic Staphylococcal Bacteriophages in mammals: kinetics of induction, immunogenic structural proteins, natural and induced antibodies","volume":"12","author":"Kazmierczak","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijmm.2025.151649_bib17","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.4049\/jimmunol.1701745","article-title":"Contribution of the immune response to phage therapy","volume":"200","author":"Krut","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.ijmm.2025.151649_bib18","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1089\/vim.2013.0128","article-title":"Phage neutralization by sera of patients receiving phage therapy","volume":"27","author":"Lusiak-Szelachowska","year":"2014","journal-title":"Viral Immunol."},{"key":"10.1016\/j.ijmm.2025.151649_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23158088","article-title":"Molecular mechanisms of drug resistance in Staphylococcus aureus","volume":"23","author":"Mlynarczyk-Bonikowska","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijmm.2025.151649_bib20","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41564-019-0634-z","article-title":"Safety of bacteriophage therapy in severe Staphylococcus aureus infection","volume":"5","author":"Petrovic Fabijan","year":"2020","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.ijmm.2025.151649_bib21","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1164\/rccm.201812-2372OC","article-title":"Bacteriophages improve outcomes in experimental Staphylococcus aureus ventilator-associated pneumonia","volume":"200","author":"Prazak","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ijmm.2025.151649_bib22","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.chom.2017.06.018","article-title":"Synergy between the host immune system and bacteriophage is essential for successful phage therapy against an acute respiratory pathogen","volume":"22","author":"Roach","year":"2017","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ijmm.2025.151649_bib23","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.virol.2007.12.013","article-title":"Fc receptor-mediated, antibody-dependent enhancement of bacteriophage lambda-mediated gene transfer in mammalian cells","volume":"373","author":"Sapinoro","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.ijmm.2025.151649_bib24","doi-asserted-by":"crossref","DOI":"10.1126\/science.aat9691","article-title":"Bacteriophage trigger antiviral immunity and prevent clearance of bacterial infection","volume":"363","author":"Sweere","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.ijmm.2025.151649_bib25","doi-asserted-by":"crossref","first-page":"4483","DOI":"10.1128\/AEM.02641-08","article-title":"Isolation from sewage influent and characterization of novel Staphylococcus aureus bacteriophages with wide host ranges and potent lytic capabilities","volume":"75","author":"Synnott","year":"2009","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.ijmm.2025.151649_bib26","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41579-018-0147-4","article-title":"Methicillin-resistant Staphylococcus aureus: an overview of basic and clinical research","volume":"17","author":"Turner","year":"2019","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ijmm.2025.151649_bib27","doi-asserted-by":"crossref","unstructured":"Washizaki, A., Sakiyama, A., Ando, H., 2024. Phage-specific antibodies: are they a hurdle for the success of phage therapy? Essays in biochemistry.","DOI":"10.1042\/EBC20240024"},{"key":"10.1016\/j.ijmm.2025.151649_bib28","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/cmdc.201300325","article-title":"A beta-lactone-based antivirulence drug ameliorates Staphylococcus aureus skin infections in mice","volume":"9","author":"Weinandy","year":"2014","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ijmm.2025.151649_bib29","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1128\/AAC.49.3.1220-1221.2005","article-title":"Experimental bacteriophage protection against Staphylococcus aureus abscesses in a rabbit model","volume":"49","author":"Wills","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijmm.2025.151649_bib30","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.cell.2020.07.040","article-title":"Mortality risk profiling of Staphylococcus aureus bacteremia by multi-omic serum analysis reveals early predictive and pathogenic signatures","volume":"182","author":"Wozniak","year":"2020","journal-title":"Cell"}],"container-title":["International Journal of Medical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1438422125000050?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1438422125000050?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T20:03:45Z","timestamp":1741982625000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1438422125000050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":30,"alternative-id":["S1438422125000050"],"URL":"https:\/\/doi.org\/10.1016\/j.ijmm.2025.151649","relation":{},"ISSN":["1438-4221"],"issn-type":[{"value":"1438-4221","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pre-exposure to phage particles reduces their antibacterial therapeutic efficacy both in vitro and in vivo","name":"articletitle","label":"Article Title"},{"value":"International Journal of Medical Microbiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijmm.2025.151649","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"151649"}}